ScholarWorks@Gyeongsang National University

Browsing by Kim, IlhwanAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 7 of 7

SCIESCOPUS
A phase III, open-label, randomized study of atezolizumab in combination with carboplatin plus paclitaxel plus bevacizumab compared with pemetrexed plus cisplatin or carboplatin with stage IV non-squamous non-small cell lung cancer (NSCLC) with activating EGFR mutation or ALK translocation (ATLAS Trial).

Park, Sehhoon; Lee, Yun-Gyoo; Park, Ji Hyun; Lee, Gyeong-Won; Kang, Eun Joo; Choi, Yoon Ji; Shin, SeongHoon; Han, Ji-Youn; Lee, Suee; Kim, YuJung, et al.

ArticleIssue Date2020CitationJournal of Clinical Oncology, v.38, no.15PublisherAmerican Society of Clinical Oncology
SCIESCOPUS
Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitorsopen access

Kim, Hye Ryeon; Kang, Jung Hun; Kim, Sung Hyun; Kim, Seung Tae; Kim, Ilhwan; Min, Young Joo; Shin, Seong Hoon; Oh, Sung Yong; Lee, Gyeong-Won; Lee, Ji Hyun, et al.

ArticleIssue Date2022CitationCancers, v.14, no.14PublisherMultidisciplinary Digital Publishing Institute (MDPI)
SCIESCOPUS
Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer A Randomized Clinical Trialopen access

Jeong, Hyehyun; Yoo, Changhoon; Kim, Ilhwan; Kang, Jung Hun; Jeong, Jae Ho; Park, Kwonoh; Oh, Sang-Bo; Park, Inkeun; Sym, Sun Jin; Cheon, Jaekyung, et al.

ArticleIssue Date2025CitationJAMA Network Open, v.8, no.10PublisherAMER MEDICAL ASSOC
SCIESCOPUS
Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: Multicenter study of the Korean Cancer Study Group (KCSG).

Chon, Hongjae; Park, Hyung Soon; Kang, Beodeul; Im, Hyeon-Su; Lee, Choong-kun; Kim, Ilhwan; Kang, Myoung Joo; Hwang, Jun-Eul; Kyun, Woo; Cheon, Jaekyung, et al.

ArticleIssue Date2020CitationJournal of Clinical Oncology, v.38, no.15PublisherAmerican Society of Clinical Oncology
SCIESCOPUS
Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib

Lim, Dong-Hoon; Casadei-Gardini, Andrea; Lee, Myung Ah; Lonardi, Sara; Kim, Jin Won; Masi, Gianluca; Chon, Hong Jae; Rimini, Margherita; Kim, Ilhwan; Cheon, Jaekyung, et al.

ArticleIssue Date2022CitationFuture Oncology, v.18, no.27, pp 3021 - 3030PublisherFuture Medicine Ltd.
SCIESCOPUS
Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study

Kim, Hyung-Don; Bang, Yeonghak; Lee, Myung Ah; Kim, Jin Won; Kim, Jee Hyun; Chon, Hong Jae; Kang, Beodeul; Kang, Myoung Joo; Kim, Ilhwan; Cheon, Jaekyung, et al.

ArticleIssue Date2020CitationLIVER INTERNATIONAL, v.40, no.10, pp 2544 - 2552PublisherWILEY
SCIESCOPUS
Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events

Yoo, Changhoon; Byeon, Seonggyu; Bang, Yeonghak; Cheon, Jaekyung; Kim, Jin W.; Kim, Jee H.; Chon, Hong J.; Kang, Beodeul; Kang, Myoung J.; Kim, Ilhwan, et al.

ArticleIssue Date2020CitationLIVER INTERNATIONAL, v.40, no.9, pp 2263 - 2271PublisherWILEY
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어